Differences in efficacy and safety of lubiprostone used for idiopathic vs opioid-induced constipation: meta-analysis of East Asian and Western populations

Clicks: 309
ID: 119308
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #7 of 14 articles by views in journal of clinical biochemistry and nutrition

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Several secretagogues, such as lubiprostone, have been developed for the treatment of constipation in the last 10 years. It is unclear whether the efficacy of lubiprostone for spontaneous bowel movement (SBM) and the adverse events are similar between idiopathic and opioid-induced constipation and b …
Reference Key
m2020journaldifferences Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sugimoto M;Murata M;Mizuno H;;
Journal journal of clinical biochemistry and nutrition
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32523244/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review pubmed abstract nih national institutes of health national library of medicine masaki murata mitsushige sugimoto hitomi mizuno pmid:32523244 pmc7263933 doi:10.3164/jcbn.19-118

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.